Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders
Joanne Coyle, Amy Rogers, Rachel Copland, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 3, pp. 1031-1042
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report
Lori Ann Eldridge, Beth E. Meyerson, Jon Agley
JMIR Formative Research (2024) Vol. 8, pp. e54077-e54077
Open Access | Times Cited: 1
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
Isla S. Mackenzie, C J Hawkey, Ian Ford, et al.
Health Technology Assessment (2024), pp. 1-55
Open Access | Times Cited: 1
Parents' and children's needs in the drug development process
Maria Cavaller-Bellaubi, Ariane Weinman, Eric Vermeulen, et al.
Elsevier eBooks (2024), pp. 33-60
Closed Access | Times Cited: 1
Clinical trials in health-care metaverse – A conceptual overview
J. Mohammed Sulaiman Sait, S Sarumathy
Perspectives in Clinical Research (2024) Vol. 16, Iss. 1, pp. 9-13
Open Access | Times Cited: 1
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches
Amos J. de Jong, Mira G. P. Zuidgeest, Yared Santa‐Ana‐Téllez, et al.
Drug Discovery Today (2024), pp. 104180-104180
Open Access | Times Cited: 1
What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?
Julia Kopanz, Bart Lagerwaard, Magdalena Beran, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 1
Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden
Opeyemi Bolajoko, Dottington Fullwood, Mahin Colissa, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 1
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges
Job F. M. van Boven, Richard W. Costello, Kit C. B. Roes, et al.
The Lancet Respiratory Medicine (2024)
Closed Access | Times Cited: 1
Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study
Robin Chatters, Cindy Cooper, Alicia O’Cathain, et al.
BMC Medical Research Methodology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Decentralised clinical trials in multiple sclerosis research
Afagh Garjani, Brandon Jun-Yu Liu, Christopher Allen, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 3, pp. 317-325
Open Access | Times Cited: 6
A Systematic Review of Methods used to Conduct Decentralised Clinical Trials
Amy Rogers
(2022)
Open Access | Times Cited: 3
Patient and Public Perceptions in Canada about Decentralized and Hybrid Clinical Trials: “It’s about time we bring trials to people”
Dawn P. Richards, John Queenan, Linnea Aasen-Johnston, et al.
Research Square (Research Square) (2024)
Open Access
Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”
Dawn P. Richards, John Queenan, Linnea Aasen-Johnston, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 5, pp. 965-977
Open Access
Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study
Margaret Rosenfeld, Ariel Berlinski, Gregory S. Sawicki, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 4, pp. 739-743
Closed Access
From Innovator Result-driven to Multi-actor Impact-oriented Public–Private Partnerships: Integrating the Patient Perspective
Remco L.A. de Vrueh, Jon S. B. de Vlieger, Kristina M. Orrling, et al.
Handbook of experimental pharmacology (2024)
Closed Access
Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease
Rohit Aggarwal, Chester V. Oddis, Daniel I. Sullivan, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Factors that influence women’s enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial
Cherish Boxall, Susanne Renz, Zina Eminton, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Factors that influence women’s enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial
Cherish Boxall, Susanne Renz, Zina Eminton, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
Sarah Naz‐McLean, Andy Kim, Andrew Zimmer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
New trends in clinical trials—between complexity and the need for renewal
Celeste Cagnazzo
AboutOpen (2022) Vol. 9, pp. 42-44
Open Access | Times Cited: 1
Give and Take: Fostering Greater Participant-Centricity In A Digital Decentralized Trial Of Rare Disease Patients (Preprint)
Zeenia Framroze, Francesca Rinaldo, Emily Lewis, et al.
(2023)
Closed Access
An Observational Pilot Study using a Digital Phenotyping Approach in Patients with Major Depressive Disorder Treated with Trazodone
Jan Čermák, S Pietrucha, Alexander Nawka, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access
Precision Recruitment and Engagement of Individuals at Risk for Diabetes and Hypertension in Clinical Trials (PREDHICT): A Randomized Trial for an E-Persuasive Mobile Application to Inform Decision Making about Clinical Trials
Azizi Seixas, Shannique Richards, Jesse Moore, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 23, pp. 7115-7115
Open Access
Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report (Preprint)
Lori Ann Eldridge, Beth E. Meyerson, Jon Agley
(2023)
Open Access
The Digital Platform and Its Emerging Role in Decentralized Clinical Trials (Preprint)
Rachel Copland, Sten Hanke, Amy Rogers, et al.
(2023)
Closed Access
Previous Page - Page 2

Scroll to top